Axios @axios
An FDA advisory panel may have green-lit a third shot of the Pfizer vaccine for a somewhat narrow slice of the population, but the messy process of figuring out who should get another shot of the vaccine — and when — has likely just begun. https://t.co/Wyijj9OuhV — PolitiTweet.org